Login
$CLOV
$4.63 +$0.07 (1.54%) Close

$CLOV 4 SEC Filings

Filed On Filing
20 Oct 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 4,066 shares ($17.9K)

20 Oct 2026 Form 4: Soares Karen, Chief Legal Officer

Sold 19,275 shares ($89.8K)

19 Oct 2026 Form 4: Toy Andrew, Director

Sold 62,176 shares ($291K)

19 Oct 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 18,273 shares ($85.5K)

19 Oct 2026 Form 4: Wai Conrad, CEO, Counterpart Health

Sold 23,627 shares ($111K)

19 Oct 2026 Form 4: Soares Karen, Chief Legal Officer

Sold 14,673 shares ($68.7K)

19 Oct 2026 Form 4: Thornton Joseph Clay, Interim CFO

Sold 4,591 shares ($21.5K)

07 Oct 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 2,006 shares ($9.29K)

05 Oct 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 8,750 shares ($38.7K)

02 Oct 2026 Form 4: Torricelli Robert G, Director

Received 12,481 shares as a grant or award

02 Oct 2026 Form 4: Miller Brian James, Director

Received 12,481 shares as a grant or award

02 Oct 2026 Form 4: Toy Andrew, Director

Sold 318,806 shares ($1.34M)

18 Sep 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 1,921 shares ($8.76K)

17 Sep 2026 Form 4: Oldakowski Joseph Frank, VP OF FINANCE AND CONTROLLER

Sold 3,170 shares ($14.7K)

16 Sep 2026 Form 4: Wai Conrad, CEO, Counterpart Health

Sold 300,000 shares ($1.42M)

15 Sep 2026 Form 4: Soares Karen, Chief Legal Officer

Sold 6,846 shares ($32.7K)

15 Sep 2026 Form 4: Reynoso Jamie L., CEO, Medicare Advantage

Sold 9,273 shares ($44.3K)

14 Sep 2026 Form 4: Oldakowski Joseph Frank, VP OF FINANCE AND CONTROLLER

Sold 20,000 shares ($103K)

17 Aug 2026 Form 4: Thornton Joseph Clay, Interim CFO

Sold 17,775 shares ($78K)

13 Aug 2026 Form 4: Soares Karen, Chief Legal Officer

Received 108,695 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support